SecSonar.com

Treace Medical Concepts, Inc. (TMCI)

Treace Medical Concepts, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Treace Medical Concepts, Inc. (TMCI) is a Medical - Devices company based in US with a market capitalization of $218.9M. Revenue grew 1.6% year-over-year and free cash flow was negative at -$29.5M. This page tracks TMCI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 477 employees · IPO Apr 23, 2021

Valuation

Valuation & price

$2.66 · as of May 17, 2026 · -65.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.51

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$7.70$4.46$1.22Jul 25Dec 25Jun 26Jul 7, 25$6.05Jul 9, 25$6.22Jul 11, 25$6.00Jul 15, 25$5.75Jul 17, 25$5.79Jul 21, 25$5.72Jul 23, 25$6.08Jul 25, 25$5.70Jul 29, 25$5.60Jul 31, 25$5.37Aug 4, 25$5.61Aug 6, 25$5.47Aug 8, 25$6.13Aug 12, 25$6.53Aug 14, 25$6.95Aug 18, 25$7.04Aug 20, 25$7.14Aug 22, 25$7.70Aug 27, 25$7.42Aug 29, 25$7.34Sep 3, 25$7.25Sep 5, 25$7.17Sep 9, 25$7.40Sep 11, 25$7.44Sep 15, 25$7.22Sep 17, 25$7.04Sep 19, 25$6.89Sep 23, 25$6.80Sep 25, 25$6.68Sep 29, 25$6.72Oct 1, 25$6.32Oct 3, 25$6.36Oct 7, 25$6.00Oct 9, 25$6.03Oct 13, 25$6.00Oct 16, 25$6.38Oct 20, 25$6.80Oct 22, 25$6.86Oct 24, 25$6.87Oct 28, 25$6.84Oct 30, 25$6.35Nov 3, 25$6.59Nov 5, 25$6.25Nov 7, 25$4.47Nov 11, 25$3.36Nov 13, 25$3.14Nov 17, 25$2.89Nov 19, 25$2.72Nov 21, 25$2.86Nov 25, 25$3.09Nov 28, 25$2.98Dec 2, 25$2.70Dec 5, 25$2.74Dec 9, 25$2.78Dec 11, 25$2.91Dec 15, 25$2.77Dec 17, 25$2.58Dec 19, 25$2.57Dec 23, 25$2.38Dec 26, 25$2.42Dec 30, 25$2.48Jan 2, 26$2.50Jan 6, 26$2.92Jan 8, 26$2.96Jan 12, 26$2.80Jan 14, 26$2.70Jan 16, 26$2.64Jan 21, 26$2.61Jan 23, 26$2.58Jan 28, 26$2.40Jan 30, 26$2.32Feb 3, 26$2.09Feb 5, 26$2.04Feb 9, 26$2.21Feb 11, 26$2.02Feb 13, 26$1.86Feb 18, 26$1.85Feb 20, 26$1.89Feb 24, 26$1.97Feb 26, 26$2.10Mar 2, 26$1.66Mar 4, 26$1.47Mar 6, 26$1.43Mar 10, 26$1.48Mar 12, 26$1.35Mar 16, 26$1.42Mar 19, 26$1.31Mar 23, 26$1.26Mar 25, 26$1.26Mar 27, 26$1.22Mar 31, 26$1.34Apr 2, 26$1.45Apr 7, 26$1.34Apr 9, 26$1.53Apr 13, 26$2.01Apr 15, 26$2.23Apr 17, 26$1.94Apr 21, 26$1.83Apr 23, 26$1.82Apr 27, 26$1.92Apr 29, 26$1.78May 1, 26$1.86May 5, 26$1.88May 8, 26$2.01May 12, 26$2.30May 14, 26$2.77May 18, 26$2.75May 20, 26$2.82May 22, 26$2.78May 27, 26$2.90May 29, 26$3.46Jun 2, 26$3.47Jun 4, 26$3.69Jun 8, 26$3.53Jun 10, 26$4.23Jun 12, 26$4.06Jun 16, 26$4.12Jun 18, 26$4.19Jun 23, 26$4.49Jun 29, 26$4.32
$1.2052-week range$7.70
Loading valuation history…

Fundamentals

Key fundamentals

$218.9M

Market cap

1.6%

Revenue growth (YoY)

79.8%

Gross margin

-$29.5M

Free cash flow (USD)

-$34.4M

Net debt

Net cash position

1.9%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$39.4MFY 2020$57.4MFY 2021$94.4MFY 2022$141.8MFY 2023$187.1MFY 2024$209.4MFY 2025$212.7M
$39.4M$212.7M

Free cash flow by year

2019 → 2025

FY 2019$-8.9MFY 2020$-5.6MFY 2021$-19.9MFY 2022$-45.5MFY 2023$-46.0MFY 2024$-48.8MFY 2025$-29.5M
-$8.9M-$29.5M

Gross margin by year

2021 → 2025

FY 202182.1%FY 202280.6%FY 202381.2%FY 202480.4%FY 202579.8%
82.1%79.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

5

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Insider buyInsider Buy $99KTreace John T. · Director, Chief Executive Officer, 10% Owner · $99.2KJun 12, 2026Filing
  • Insider buyInsider Buy $211KTreace John T. · Director, Chief Executive Officer, 10% Owner · $211KJun 11, 2026Filing
  • Insider buyInsider Buy $178KTreace John T. · Director, Chief Executive Officer, 10% Owner · $177.9KJun 1, 2026Filing
  • Insider buyInsider Buy $341KTreace John T. · Director, Chief Executive Officer, 10% Owner · $340.6KMay 28, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 20, 2026Filing
  • Insider buyInsider Buy $376KTreace John T. · Director, Chief Executive Officer, 10% Owner · $375.5KMay 14, 2026Filing
  • 8-K eventEarnings ReleaseMay 8, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventExecutive DepartureApr 9, 2026Filing

Questions

Frequently asked questions

What is Treace Medical Concepts, Inc.'s market cap?

Treace Medical Concepts, Inc. (TMCI) has a market capitalization of $218.9M.

What is TMCI's P/E ratio?

A meaningful P/E ratio is not available for TMCI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is TMCI's price-to-book (P/B) ratio?

TMCI trades at 2.51 times book value per share.

Are insiders buying TMCI stock?

Yes — SEC Form 4 filings show 5 open-market insider buys and 0 sells at Treace Medical Concepts, Inc. in the last 90 days.

Same arena

Related companies in Medical - Devices

RXST

RxSight, Inc.

$228.9M

PROF

Profound Medical Corp.

$207.1M

ANIK

Anika Therapeutics, Inc.

$196.4M

INGN

Inogen, Inc.

$177.3M

APYX

Apyx Medical Corporation

$175.7M

SGHT

Sight Sciences, Inc.

$270.1M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.